Current Assets
Total Current Assets
Edwards Lifesciences Total Current Assets decreased by 7.6% to $6.23B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 0.3%, from $6.21B to $6.23B. Over 5 years (FY 2020 to FY 2025), Total Current Assets shows an upward trend with a 16.9% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryLiquidity
SignalHigher is better
VolatilityModerate
First reportedQ4 2014
Last reportedQ1 2026
How to read this metric
A higher value relative to current liabilities indicates a strong safety margin for meeting short-term obligations.
Detailed definition
The sum of all assets that are reasonably expected to be converted into cash or consumed within one year. This aggregate...
Peer comparison
High-growth tech companies often maintain high current asset levels to support rapid scaling and R&D needs.
Metric ID:
total_current_assetsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.32B | $3.52B | $3.18B | $3.24B | $3.26B | $3.51B | $3.10B | $3.26B | $3.65B | $4.07B | $4.04B | $4.17B | $4.52B | $6.73B | $6.29B | $6.21B | $6.58B | $6.36B | $6.74B | $6.23B |
| QoQ Change | — | +5.8% | -9.5% | +1.9% | +0.7% | +7.7% | -11.9% | +5.2% | +12.0% | +11.5% | -0.8% | +3.3% | +8.3% | +49.0% | -6.6% | -1.2% | +5.9% | -3.3% | +6.0% | -7.6% |
| YoY Change | — | — | — | — | -1.8% | -0.0% | -2.7% | +0.5% | +11.8% | +15.8% | +30.4% | +28.0% | +23.8% | +65.4% | +55.7% | +49.0% | +45.6% | -5.5% | +7.2% | +0.3% |
Range$3.10B – $6.74B
CAGR+14.1%
Avg YoY Growth+20.2%
Median YoY Growth+13.8%
Total Current Assets at Other Companies
Frequently Asked Questions
- What is Edwards Lifesciences's total current assets?
- Edwards Lifesciences (EW) reported total current assets of $6.23B in Q1 2026.
- How has Edwards Lifesciences's total current assets changed year-over-year?
- Edwards Lifesciences's total current assets increased by 0.3% year-over-year, from $6.21B to $6.23B.
- What is the long-term trend for Edwards Lifesciences's total current assets?
- Over 5 years (2020 to 2025), Edwards Lifesciences's total current assets has grown at a 16.9% compound annual growth rate (CAGR), from $3.09B to $6.74B.
- What does total current assets mean?
- Everything the company owns that can be turned into cash within a single year.